Research Article

Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support

Table 3

Survival and safety outcomes.

Impella 2.5 (n = 65)Survivors (n = 29)Nonsurvivors (n = 36) valueImpella CP (N = 32)Survivors (N = 14)Nonsurvivors (N = 18) value

Survival to hospital discharge, n (%)29 (44.6)29 (100)14 (43.8)14 (100)
 CPC 1–2, n (%)22 (75.9)22 (75.9)11 (78.6)11 (78.6)
 CPC 3–4, n (%)7 (24.1)7 (24.1)3 (21.4)3 (21.4)

Causes of death
Cardiogenic shock/MOF, n (%)33 (50.8)33 (91.7)15 (83.3)
Brain death, n (%)3 (4.6)3 (8.3)3 (16.7)

Complications
Access-site bleeding requiring transfusion, n (%)6 (9.2)3 (10.3)3 (8.3)17 (21.9)3 (21.4)4 (22.2)1
Limb ischemia requiring extraction of the device, n (%)3 (4.6)1 (3.4)2 (5.6)15 (15.7)2 (14.3)3 (16.7)1
Limb ischemia requiring intervention, n (%)2 (3.1)1 (3.4)1 (2.8)14 (12.5)2 (14.3)2 (11.1)1
Pericardial effusion needing paracentesis, n (%)1 (1.5)1 (2.5)0 (0)11 (3.1)0 (0)1 (5.6)1
Myocardial reinfarction, n (%)0 (0)0 (0)0 (0)10 (0)0 (0)0 (0)1
Stroke, n (%)0 (0)0 (0)0 (0)11 (3.1)0 (0)1 (5.6)1
Nondevice-related bleeding, n (%)3 (4.6)1 (3.6)2 (5.6)12 (6.3)1 (7.1)1 (5.6)1

CPC: cerebral performance category; MOF: multiorgan failure. Numbers are presented as frequencies (percentile).